Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment by Timothée Olivier, Vinay Prasad

Get full text

Elacestrant in metastatic breast cancer: Is the “standard of care” meeting standard requirements? by Timothée Olivier, Vinay Prasad

Get full text

Neoadjuvant checkpoint inhibition in non-small cell lung cancer: Is earlier unquestionably better than later? by Timothée Olivier, Vinay Prasad

Get full text

Neoadjuvant followed by adjuvant pembrolizumab in melanoma: time biases in the data analysis of the SWOG S1801 trial. by Timothée Olivier, Vinay Prasad

Get full text

Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines by Timothée Olivier, Vinay Prasad

Get full text

Tebentafusp in first-line melanoma trials: An outperforming outlier by Timothée Olivier, Vinay Prasad

Get full text

A novel trial methodology to test interventions with very large effect sizes: the case of dostarlimab in mismatch repair-deficient, locally advanced rectal cancer by Kerrington Powell, Timothée Olivier, Vinay Prasad

Get full text

Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer by Timothée Olivier, Alyson Haslam, Vinay Prasad

Get full text

Sotorasib in KRASG12C mutated lung cancer: Can we rule out cracking KRAS led to worse overall survival? by Timothée Olivier, Alyson Haslam, Vinay Prasad

Get full text

Post-progression treatment in cancer randomized trials: a cross-sectional study of trials leading to FDA approval and published trials between 2018 and 2020 by Timothée Olivier, Alyson Haslam, Vinay Prasad

Get full text

Umbrella review of basket trials testing a drug in tumors with actionable genetic biomarkers by Alyson Haslam, Timothée Olivier, Jordan Tuia, Vinay Prasad

Get full text

What drives cancer clinical trial accrual? An empirical analysis of studies leading to FDA authorisation (2015–2020) by Vinay Prasad, Kristina Jenei, Alyson Haslam, Timothée Olivier, Milos Miljkovíc

Get full text

Immune checkpoint inhibitor-induced aseptic meningitis and encephalitis: a case-series and narrative review by Laure Thouvenin, Timothée Olivier, Giuseppe Banna, Alfredo Addeo, Alex Friedlaender

Get full text